Other GLP-1 receptor agonists include semaglutide (Wegovy for weight management, Ozempic for diabetes) and liraglutide (Saxenda for weight management, Victoza for diabetes), with semaglutide 2.4 mg demonstrating greater average weight loss than liraglutide 3.0 mg in clinical trials
Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: A narrative review
DSIP For deep sleep and circadian rhythm regulation
It helps make methionine, an amino acid needed for S-adenosylmethionine (SAMe) , which is vital for body processes
Combining Lipo B with Lipo C Synergy or Redundancy
Copper Peptides: The Scalp Rejuvenator Copper peptides act more like a nutrient-rich organic compost for the scalp